DRL launches Ezetimibe and Simvastatin tablets in the US

They are a therapeutic equivalent generic version of Vytorin Tablets

Dr Reddy’s Laboratories (DRL) has launched Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg, a therapeutic equivalent generic version of Vytorin Tablets in the US market, approved by US FDA.

The Vytorin brand had the US sales of approximately $678 million MAT for the most recent twelve months ended in February 2017, according to IMS Health.

DRL’s Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20mg, 10 mg/40 mg, and 10 mg/80 mg, are available in bottle count sizes of 30, 90 and 1000.